INTEGRATING GENOMICS AND TRANSCRIPTOMICS TO RESHAPE PRECISION ONCOLOGY:
|
|||
Sunday 30 October 2022 |
|||
SESSION 3 – DISRUPTIVE CONCEPTS AND METHODOLOGICAL INNOVATIONS IN NSCLC: MEET THE EXPERTS |
|||
|
Keynote Lecture Advances in Lung Cancer |
Solange Peters |
President ESMO, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland |
|
Early stage lung cancer: challenge and opportunity |
Haiquan Chen |
Fudan University, Shanghai, China |
|
Neoadjuvant and adjuvant strategies in NSCLC |
Enriqueta Felip |
Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain |
|
A focus on emerging paradigms in the treatment of early NSCLC |
Jair Bar |
Chaim Sheba Medical Center, Ramat Gan, Israel |
|
From chest x ray to AI-assisted lung cancer screening and early detection program in Israel |
Amir Onn |
Chaim Sheba Medical Center, Ramat Gan, Israel |
|
New drugs for SCLC |
Pilar Garrido |
Universidad de Alcalá, Madrid, Spain |
Coffee and Networking |
|||
SESSION 4 - WIN FIRST INTERNATIONAL MOLECULAR TUMOR BOARD: A STRATEGIC PLACE IN ADVANCING PRECISION ONCOLOGY |
|||
|
First WIN International Molecular Tumor Board Introduction Patients' cases presentation by investigators. Discussion and treatment recommendation |
Moderator Razelle Kurzrock |
WIN Consortium, Villejuif, France |
Panel Discussion and Q&A from the audience |
|||
Lunch, poster viewing and networking |
|||
SESSION 5 – WHAT IS NEW IN BREAST, CRC, OVARY, HEAD & NECK, PEDIATRIC AND OTHER CANCERS? |
|||
|
Opening Keynote Lecture The BIG AURORA molecular screening program for metastatic breast cancer: first results |
Martine Piccart |
Institut Jules Bordet, Brussels, Belgium |
|
Keynote Lecture Novel CRC insights based on combined genomic and |
Sabine Tejpar |
University of Leuven, Belgium |
|
Serial profiling in metastatic CRC; beyond the tip of the |
Gerald Batist |
Segal Cancer Centre, Lady Davis Institute at the JGH, McGill University, Montréal, Canada |
|
Paradigm shift in treatment of ovarian cancers |
Matthew Ellis |
AstraZeneca, Gaithersburg, Maryland, USA |
|
Novel strategies in head & neck cancers |
Christophe Le Tourneau |
Institut Curie, Paris, France |
|
Novel strategies in prostate cancer (TBC) or Novel strategies in melanoma (TBC) |
|
|
|
Pediatric European Precision Cancer Medicine Program - Facing cancer complexity |
Birgit Geoerger |
Gustave Roussy, Villejuif, France |
BEST TWO POSTERS' PRESENTATIONS AND AWARDS Josep Tabernero, Vice-Chairman WIN Consortium, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain Amir Onn, Head of the Standard Operating Procedures and repository Committee WIN Consortium |
|||
CONCLUSIONS Richard L. Schilsky, Chairman WIN Consortium |
Download the WIN 2022 Program

WIN 2022 Symposium
c/o MCI UK Ltd
Ground Floor, Building 1000
Western Road
Portsmouth, Hampshire
PO6 3EZ, UK
Tel: +44 (0) 1730 715223
General enquiries: winsymposium@mci-group.com
Sponsorship enquiries: winsymposium@mci-group.com
Abstract enquiries: winsympabstracts@mci-group.com
Registration enquiries: winsympreghot@mci-group.com